NTCP inhibitor (KU Leuven’s Centre for Drug Design and Discovery)

N/A

Report date: 2025/03/20 10:06:09
NME

Base Information

Drug NameNTCP inhibitor (KU Leuven’s Centre for Drug Design and Discovery)
Drug Alias NameSLC10A1 inhibitor (KU Leuven’s Centre for Drug Design and Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/bile acid cotransporter inhibitors
TargetsSodium/bile acid cotransporter
Therapy Area/IndicationsCholangitis, SclerosingHepatitis DHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKU Leuven’s Centre for Drug Design and Discovery
China Registration ClassN/A

Develop Information

Active CompaniesKU Leuven’s Centre for Drug Design and Discovery
Inactive CompaniesN/A
Active IndicationsCholangitis, SclerosingHepatitis DHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A